Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis
- PMID: 28404156
- PMCID: PMC5713894
- DOI: 10.1016/S2468-1253(17)30004-3
Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis
Abstract
Background: The increased risk of colorectal cancer in ulcerative colitis is well known. The risk of sporadic colorectal cancer in Asian populations is considered low and risk estimates of colorectal cancer related to ulcerative colitis from Asia vary. This meta-analysis is an Asian perspective on the risk of colorectal cancer related to ulcerative colitis.
Methods: We searched PubMed and Embase for terms related to colorectal cancer in ulcerative colitis from inception to July 1, 2016. The search for published articles was done by country for all countries in Asia. We included studies with information on the prevalence and cumulative risk of colorectal cancer at various timepoints. A random-effects meta-analysis was done to calculate the pooled prevalence as well as a cumulative risk at 10 years, 20 years, and 30 years of disease.
Findings: Our search identified 2575 articles; of which 44 were eligible for inclusion. Our analysis included a total of 31 287 patients with ulcerative colitis with a total of 293 reported colorectal cancers. Using pooled prevalence estimates from various studies, the overall prevalence was 0·85% (95% CI 0·65-1·04). The risks for colorectal cancer were 0·02% (95% CI 0·00-0·04) at 10 years, 4·81% (3·26-6·36) at 20 years, and 13·91% (7·09-20·72) at 30 years. Subgroup analysis by stratifying the studies according to region or period of the study did not reveal any significant differences.
Interpretation: We found the risk of colorectal cancer in Asian patients with ulcerative colitis was similar to recent estimates in Europe and North America. Adherence to screening is therefore necessary. Larger population-based, prospective studies are required for better estimates of the risk.
Funding: Indo-US Science and Technology Forum.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Figures





Comment in
-
Colon cancer in Asian patients with ulcerative colitis.Lancet Gastroenterol Hepatol. 2017 Apr;2(4):238-239. doi: 10.1016/S2468-1253(17)30032-8. Epub 2017 Feb 21. Lancet Gastroenterol Hepatol. 2017. PMID: 28404142 No abstract available.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000279. doi: 10.1002/14651858.CD000279.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2017 Sep 18;9:CD000279. doi: 10.1002/14651858.CD000279.pub4. PMID: 16625534 Updated.
-
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.Cochrane Database Syst Rev. 2004;(2):CD000279. doi: 10.1002/14651858.CD000279.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000279. doi: 10.1002/14651858.CD000279.pub3. PMID: 15106148 Updated.
-
Interventions for promoting habitual exercise in people living with and beyond cancer.Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3. Cochrane Database Syst Rev. 2018. PMID: 30229557 Free PMC article.
Cited by
-
"Two-birds-one-stone" colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis.J Nanobiotechnology. 2022 Aug 30;20(1):389. doi: 10.1186/s12951-022-01598-0. J Nanobiotechnology. 2022. PMID: 36042499 Free PMC article.
-
Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.Inflamm Intest Dis. 2017 Nov;2(2):102-115. doi: 10.1159/000465522. Epub 2017 Apr 8. Inflamm Intest Dis. 2017. PMID: 30018961 Free PMC article. Review.
-
Update and latest advances in mechanisms and management of colitis-associated colorectal cancer.World J Gastrointest Oncol. 2023 Aug 15;15(8):1317-1331. doi: 10.4251/wjgo.v15.i8.1317. World J Gastrointest Oncol. 2023. PMID: 37663937 Free PMC article. Review.
-
Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method.Yonsei Med J. 2021 Nov;62(11):997-1004. doi: 10.3349/ymj.2021.62.11.997. Yonsei Med J. 2021. PMID: 34672133 Free PMC article.
-
Development and Initial Use of a New Inflammatory Bowel Disease Clinical Database Integrating Both Eastern and Western Clinical Characteristics.Chronic Dis Transl Med. 2025 Feb 14;11(2):130-139. doi: 10.1002/cdt3.70000. eCollection 2025 Jun. Chronic Dis Transl Med. 2025. PMID: 40486950 Free PMC article.
References
-
- Ahuja V, Tandon RK. Inflammatory bowel disease: the Indian augury. Indian J Gastroenterol. 2012;31:294–96. - PubMed
-
- Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional diff erences. J Dig Dis. 2010;11:134–47. - PubMed
-
- Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens. 1999;53:350–58. - PubMed
-
- Cheon JH. Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives. J Gastroenterol Hepatol. 2013;28:220–26. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials